Loading
companiesCompany
EORTC
aka European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer - EORTC
EORTC is Europe's academic cancer trials organisation and has run practice-changing trials since 1962.
Overview
EORTC, the European Organisation for Research and Treatment of Cancer in Brussels, is Europe's academic cancer trials organisation and has run practice-changing trials since 1962. Its record includes the sarcoma hyperthermia trial 62961, the melanoma adjuvant trial 1325, the glioma trial 26951 and Stupp's 2005 trial that added temozolomide to radiotherapy for glioblastoma, together with the QLQ-C30 quality of life instruments, with Alexander Eggermont, Denis Lacombe, Michael Weller and Roger Stupp among the people OnCo lists. It is linked to bottlenecks on rare cancers without markets and undervalued quality of life, and to ideas such as mutual recognition of ethics review across countries. How an academic group sustains phase 3 trials that no company will pay for is the standing question. Its trial and quality of life programmes are listed in the notes.
Alexander Eggermont
Chief Scientific Officer, Princess Máxima Center; Professor, Utrecht; former EORTC President
MelanomaAdjuvant immunotherapySurgical oncology
Surgical oncologist who led the EORTC adjuvant ipilimumab and pembrolizumab trials in melanoma.
Denis Lacombe
Chief Executive Officer, EORTC
Clinical trial methodologyAcademic research infrastructureHealth policy
Denis Lacombe leads Europe's academic cancer trials organisation.
Michael Weller
Chair, Department of Neurology, University Hospital Zurich; Chair, EORTC Brain Tumor Group
Neuro-oncologyGliomaClinical trials
Neuro-oncologist who leads the EORTC Brain Tumor Group and co-authors the European glioma guidelines.
Roger Stupp
Professor of Neurological Surgery and Neurology, Northwestern University; formerly Lausanne and EORTC
Neuro-oncologyGlioblastomaTumour treating fields
Led the EORTC/NCIC trial that made temozolomide with radiotherapy the glioblastoma standard, and the EF-14 trial of tumour treating fields.
Ulrich Keilholz
Director, Charité Comprehensive Cancer Center
MelanomaHead and neck cancerImmunotherapy
Ulrich Keilholz is a medical oncologist who directs the Charité Comprehensive Cancer Center.
Notes
top- Academic phase 3 trials
- Quality of life research
Similar pages
not linked directly; found by shared links- CompanyBreast International Group (BIG)
Shares Comprehensive Cancer Center Vienna, Medical University of Vienna / AKH, Institut Jules Bordet, Secrecy and intellectual property block collaboration and the tag cooperative-group.
- CompanyChildren's Cancer and Leukaemia Group
Shares SIOP Europe (European Society for Paediatric Oncology), Sarcomas (soft tissue, bone, GIST), Glioma & glioblastoma and the tag cooperative-group.
- CompanyECOG-ACRIN Cancer Research Group
Shares A fixed share of trial-group funding for getting proven care to patients, Secrecy and intellectual property block collaboration and the tag cooperative-group.
- CompanyUNICANCER
Shares ARCAGY-GINECO, Intergroupe Francophone de Cancérologie Thoracique and the tag cooperative-group.
- CompanyChildren's Oncology Group (COG)
Shares Inflammatory myofibroblastic tumour (IMT), SIOP Europe (European Society for Paediatric Oncology), Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST) and the tag cooperative-group.
- CompanyETOP IBCSG Partners Foundation
Shares Intergroupe Francophone de Cancérologie Thoracique and the tag cooperative-group.
- CompanyGOG Foundation
Shares ARCAGY-GINECO and the tag cooperative-group.
- CompanyGerman Breast Group (GBG)
Shares Secrecy and intellectual property block collaboration and the tag cooperative-group.
cancers
3companies
2institutions
13Comprehensive Cancer Center Vienna, Medical University of Vienna / AKHEuropean Cancer OrganisationEuropean Medicines AgencyEuropean Society for Radiotherapy and OncologyEuropean Society of Surgical OncologyInstitut Jules BordetInternational Society for Quality of Life ResearchLausanne University Hospital (CHUV) / Ludwig Institute LausanneMaria Skłodowska-Curie National Research Institute of OncologyPrincess Máxima Center for Pediatric OncologySIOP Europe (European Society for Paediatric Oncology)University Hospital Zurich / Comprehensive Cancer Center ZurichUZ Leuven / Leuven Cancer Institute
trials
5ideas
9A fixed share of trial-group funding for getting proven care to patientsA global first-in-human network for academic cancer trials with single ethics reviewA national non-profit contract research organisation for academic oncology trialsDrop the 'must speak English' rule: translated consent and questionnaires as standardMutual recognition of ethics review across countriesOne global rare cancer network with n-of-1 and Bayesian trial frameworksOpen-source protocol and statistical analysis plan templates with runnable codeTime to treatment failure and quality of life as co-primary endpoints in non-curative trialsTrial-in-a-box: a preconfigured protocol kit any hospital can open for a rare cancer